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Abstract
Purpose Protective occlusion of the gastroduodenal
artery (GDA) is required to avoid severe adverse effects
and complications in radioembolization procedures.
Because of the expandable features of HydroCoils, our goal
was to occlude the GDA with only one HydroCoil to
provide particle reflux protection.
Methods Twenty-three subjects with unresectable liver
tumors, who were scheduled for protective occlusion of the
GDA before radioembolization therapy, were included.
The primary end point was to achieve a proximal occlusion
of the GDA with only one detachable HydroCoil. Evalu-
ated parameters were duration of deployment, and early
(during the intervention) and late (7–21 days) occlusion
rates of GDA. Secondary end points included complete
duration of the intervention, amount of contrast medium
used, fluoroscopy rates, and adverse effects.
Results In all cases, the GDA was successfully occluded
with only one HydroCoil. The selected diameter/length
range was 4/10 mm in 2 patients, 4/15 mm in 6 patients,
and 4/20 mm in 15 patients. HydroCoils were implanted,
on average, 3.75 mm from the origin of the GDA (range
1.5–6.8 mm), with an average deployment time of 2:47
(median 2:42, range 2:30–3:07) min. In 21 (91%) of 23
patients, a complete occlusion of the GDA was achieved
during the first 30 min after the coil implantation; however,
in all patients, a late occlusion of the GDA was present
after 6 to 29 days. No clinical or technical complications
were reported.
Conclusion We demonstrated that occlusion of the GDA
with a single HydroCoil is a safe procedure and successfully
prevents extrahepatic embolization before radioembolization.
Keywords Clinical practice  Embolization 
Embolotherapy  Interventional oncology  Liver/hepatic 
Radiation protection
Introduction
Selective internal radioembolization is a catheter-based,
liver-directed therapy that involves the injection of micron-
sized embolic particles loaded with a radioisotope using
percutaneous transarterial techniques. Unlike other loco-
regional therapies, preprocedure planning and meticulous
mesenteric angiography are imperative in order to deter-
mine the safest and most effective treatment strategy [1].
Protective occlusion of the gastroduodenal artery (GDA) is
frequently required before radioembolization because
extrahepatic embolization (nontarget embolization) of
yttrium-90 microspheres may lead to severe adverse effects
and complications.
For this purpose, different materials, including micro-
coils, vascular plug devices, and more recently hydrogel-
coated coils, have been used. The HydroCoil (MicroVention,
Tustin, CA) is a coil system designed to improve coil-
packing density; it comprises a layer of acrylic polymer
surrounding a platinum metallic core that increases in
thickness and diameter when in contact with liquid or blood.
Because of its unique expandable features, we proposed
that the proximal occlusion of the GDA with only one
detachable HydroCoil would be feasible and effective to
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provide protection against particle reflux in patients
scheduled for selective internal radioembolization therapy
(SIRT).
Materials and Methods
The present study was a single-center pilot study per-
formed in a tertiary clinical institute. The study protocol
was reviewed and approved by the ethics committee of our
institution and conducted in accordance with good clinical
practice (EU guideline EN ISO 14155).
Study End Points
The primary end point of this study was the proximal
occlusion of the GDA using only one HydroCoil in patients
who were undergoing SIRT. For this purpose, the Hydro-
Coil implantation time duration, and the early (during the
intervention) and late occlusion (7 to 21 days) rates of the
GDA were evaluated.
As secondary end points, several technical variables
were assessed, including complete duration of the inter-
vention (min), contrast medium doses (ml), fluoroscopy
rates, and local and systemic adverse effects.
Inclusion Criteria
Twenty-five subjects with unresectable primary and sec-
ondary liver tumors who were scheduled for radioemboli-
zation therapy were included. In all cases, the presence of
the GDA with proven antegrade flow (GDA blood flow
directed from the celiac trunk and not from the superior
mesenteric artery) had to be demonstrated.
If necessary, other vessels (right gastric artery, gastro-
epiploic artery, small duodenal arcades, cystic, left gastric
artery) were also embolized; however, these vessels were
not assessed in this study. Patients were informed of the
nature of the study, and written informed consent was
obtained before the procedure.
Exclusion Criteria
Patients were excluded if they had any condition or had
undergone any prior therapy that, in the opinion of the
clinical investigator, would make the subject unsuitable for
this study. Patients with GDA reversed flow (in these cases,
protection of the GDA is usually not required [2]), were
also excluded, as were patients with previous endovascular
embolization by coils or surgical ligature/resection of the
GDA, or with vascular anatomic variants, such as absence
of the GDA.
Descriptive and Comparative Analysis
Our results were descriptively analyzed and compared to a
similarly designed study performed by Dudeck et al. [3],
who used a fibered interlock detachable coil system versus
standard pushable coils.
Procedure
Technique
All procedures were performed with the patient under local
anesthesia via 4F femoral access. Angiographic mapping of
the mesenteric vessels, including selective angiograms
from the celiac trunk and superior mesenteric artery, were
performed with an S1 4F catheter (Cordis, Miami, FL). The
angiographic information demonstrated the patient’s vas-
cular anatomy, the presence of anatomical variants, flow
direction, and possible collateral vessels. For the coiling
procedure, superselective catheterization of the GDA was
performed with a 2.7F microcatheter (0.025 inches inner
diameter) (Terumo Europe, Heverlee, Belgium).
HydroCoil Selection and Preparation
Only 0.018-inch detachable HydroCoils were used in this
study. The decision about which diameter and length of
HydroCoil was suitable for each patient was performed
indirectly from the French calculation method: knowing
that 1F equals 0.33 mm (4F = *1.2 mm), the vessel
diameter could be calculated on the basis of the selected
catheter size. When possible, oversizing of the selected coil
was avoided by fitting the maximum coil diameter to the
vessel diameter if this was not feasible, a minimal over-
sizing to the next available diameter of HydroCoil was
accepted (i.e., a vessel of 3.9 mm was embolized with a
4.0-mm HydroCoil rather than a 5.0 mm HydroCoil). All
vessel measurements were performed by angiography at
the origin of the GDA (Fig. 1).
All detachable HydroCoils and the electromechanical
delivery device were tested before implantation according
to the manufacturer’s guidelines. To ensure optimal curl-
ing, the HydroCoil was briefly immersed (5 s) in sterile
water at 70C.
HydroCoil Implantation Zone
The HydroCoil implantation was performed only in the
most proximal segment of the GDA, where the first small
pancreatic and duodenal branches arise. If the position of
the HydroCoil was not satisfactory, repositioning was
performed. Only when the desired position was reached
was the HydroCoil detached. Angiographic control (hand
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injection of 2.5 ml contrast medium at 1 ml/s flow) was
performed immediately after the deployment (time 0) and
every 5 min sequentially until complete vascular occlusion
was observed, during a maximal period of 30 min (Fig. 2).
Median-term angiograms were performed in all patients
7 to 29 days after coiling just before at the SIRT procedure.
HydroCoil Deployment Time and Time to Occlusion
The HydroCoil deployment time was defined as the time
from when the sterile package of the HydroCoil was
opened until the HydroCoil was completely detached
within the GDA. This included the following steps: open-
ing of the sterile package; short immersion of the Hydro-
Coil in a water bath at 70C saline water; insertion of
the HydroCoil within the microcatheter; positioning of the
HydroCoil within the vessel; and detachment from the
attached deployment wire. The time for occlusion was
defined as the period between HydroCoil detachment until
angiographic evidence of complete proximal occlusion of
the GDA, measured in time intervals of 5 min.
Vascular Effects after HydroCoil Implantation
Angiographically significant flow reduction was defined as
the moment when vascular stasis was evident, but there
was not yet complete occlusion of the GDA (Fig. 3).
Results
Patient Demographics
From the 25 patients who underwent protective GDA
embolization before SIRT, the planned SIRT was canceled
in 2 patients (8%) as a result of progressively impaired liver
Fig. 1 French catheter scale. Indirect calculation of GDA diameter
using the outer diameter of the Sidewinder catheter as a reference
diameter. A 4F catheter with a well-known diameter of 1.35 mm
correlates with an approximate GDA diameter of 2.70 to 3 mm. Only
slight oversizing of the selected coil was being performed to avoid
distal coil migration (i.e., a vessel approximately 3 mm in diameter
would be embolized by a 4-mm-diameter HydroCoil)
Fig. 2 Coiling phases of GDA. A Localization of the appropriate
coiling segment. B Angiogram performed 5 min after HydroCoil
implantation still shows flow; however, a flow reduction is already
observed. C Angiogram performed 20 min after HydroCoil implan-
tation demonstrates complete occlusion of the GDA
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function parameters; thus, angiographic control of the GDA
was not possible. Therefore, the study sample included 23
patients (15 men and 8 women) with a median age of
56.2 years who had a liver or liver metastases due to the
following: pancreatic neuroendocrine tumor (n = 8), colo-
rectal carcinoma (n = 7), hepatocellular carcinoma (n = 4),
breast cancer (n = 3), and malignant melanoma (n = 1).
The median nominal diameter of the GDA before the
HydroCoil implantation was 3.58 (range 3.10–4.60) mm.
HydroCoil Placement
According to our study design, only one HydroCoil was
implanted successfully in all cases. The range of selected
diameter/length of the HydroCoils was as follows:
4/10 mm in 2 patients; 4/15 mm in 6 patients; and
4/20 mm in 15 patients. On average, the HydroCoils were
implanted as close as 3.75 (range 1.5–6.8) mm from the
origin of the GDA. The mean HydroCoil deployment time
was 2:47 (median 2:42, range 2:30–3:07) min. An angio-
graphically significant flow reduction was observed in all
patients between 5 and 10 min before complete vascular
occlusion was reached.
The desired embolization effect (time for occlusion),
demonstrated by GDA occlusion, was observed as follows:
two complete occlusions after 5 min; four complete
occlusions after 10 min; six complete occlusions after 15
and 20 min, respectively; two complete occlusions after
25 min; and one complete occlusion after 30 min. Thus, in
21 cases (91.3%), a complete occlusion occurred during the
first 30 min after GDA embolization (early occlusion),
whereas in 2 cases (8.7%), a complete occlusion of the
GDA was not visible.
However, in all patients, a late occlusion was present
after 6 to 29 (median 19) days when the late angiographic
follow-up was performed (late occlusion rate 100%, late
recanalization rate 0%). No clinical or technical compli-
cations related to the HydroCoil implantation (i.e., migra-
tion, dissection) were reported.
General Procedure Results
The mean complete duration of the procedures was 43:07
(range 22–110) min. The total dose of contrast medium
applied for the complete examination was 110 (range
90–135) ml. In each case, two initial series with 35 ml of
contrast medium were performed (35 ml at a 6 ml/s rate)
from the celiac trunk and the superior mesenteric artery.
The other series were performed to determine the position
of the microcatheter within the GDA, as well as to deter-
mine the effects of the occlusion after the HydroCoil
embolization (8 ml at 1.5 ml/s rate). Additional series to
occlude other vessels were performed in some cases, but
these vessels were not considered part of our study. The
median duration of fluoroscopy was 11:41 min for the
whole procedure (range 6:27–17:53 min), with a mean
time of 11:43 min.
Adverse Effects
There were no thromboembolic complications after
GDA HydroCoil embolization. Recognizable clots, distal
Fig. 3 Angiographically significant flow reduction. A Angiogram
1 min after device implantation. Intrahepatic vessels, as well the
GDA and the gastroepiploic artery, are equally filled with contrast.
B Angiogram performed 10 min after HydroCoil deployment clearly
shows almost complete washout of the contrast medium in the
intrahepatic arteries, whereas stasis of contrast-enhanced blood flow
within the gastroepiploic artery (white arrow) is still visible
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organ infarcts, or silent infarcts were not detected on
postprocedure computed tomographic follow-up or diffu-
sion-weighted magnetic resonance imaging.
None of the HydroCoil parts protruded (loop protrusion)
from the GDA into other vessels (hepatic artery), and no
distal migration was observed. No early liberation of
detachable coils (within the microcatheter) or malfunction
of the electromechanical delivery device were detected.
None of the patients experienced allergic reactions related
to hydrogel components or postembolization syndrome.
Discussion
We postulated that it would be possible to precisely
occlude the proximal segment of the GDA to protect
dependent territories, including the stomach, the duode-
num, the pancreas, and the colon, from severe adverse
effects as a result of the radioembolization procedures
(radioembolic-related damage). However, the proximal
occlusion technique of the GDA is not indicated for
treating bleeding sources that arise from the GDA. In these
cases, selective occlusion of the bleeding source should be
attempted, or otherwise a complete GDA occlusion is
mandatory.
Dudeck et al. [3] have already demonstrated that the use
of the fibered interlock detachable coils for occlusion of the
GDA in patients scheduled for SIRT was safe and effec-
tive, as well as associated with a shorter procedure time
compared to the standard pushable fiber coils. In their
study, a mean of 6.2 ± 1.8 standard coils were used to
embolize the GDA, whereas a mean of 1.3 ± 0.9 interlock
detachable coils were required. In our study, we further
reduced that number to only one detachable HydroCoil
necessary to achieve a satisfactory embolization result
(Table 1).
HydroCoils are recently developed embolic (coil and
microcoil) devices with a layer of hydrogel polymer sur-
rounding a platinum metallic core that swells in blood [4].
The hydrogel polymer facilitates the expansion of the
effective coil diameter up to several times its original
diameter, thus not relying on the thrombogenicity of the
blood alone, as the coil swelling results in reliable vessel
occlusion without the need for distal embolization, as our
study demonstrated [5, 6]. This particular feature can also
be helpful in patients who have an impaired coagulation
profile when other embolization materials would need
longer times to induce a vascular thrombosis or would need
more coils [4].
To our knowledge, the application of HydroCoils used
for protective coiling of the mesenteric vessels, particularly
the GDA in patients who are undergoing SIRT, has not yet
been assessed. Protective targeted embolization of the
GDA is performed before the therapeutic procedure in
order to confine the radioactive material to the liver [3, 7].
The precision of the HydroCoil deployment only a few
millimeters away from the common hepatic artery (defined
in our study as the neck, a distance that was a median of
3.7 mm) demonstrates optimal material manageability.
Repositioning the HydroCoils in cases of suboptimal
delivery did not seem to be a problem unless the electro-
mechanical mechanism had not been activated. Withdrawal
of the HydroCoil, still attached to the deployment wire, is
possible up to 5 min before the swelling, lubricated poly-
mer coating prevents further repositioning through the
microcatheter. This time span would allow repositioning of
a misplaced microcatheter and reinsertion of the HydroCoil
using the insertion sheath.
For protective embolization, it is essential to consider
that small pancreatic and duodenal branch vessels may
arise from the first millimeters of the GDA [8], also
referred to as vessels. In radioembolization, precise
placement of the embolization device in this segment is
crucial to avoid radiogenic-related complications such as
duodenitis or pancreatitis [9, 10]. This is a valuable feature
that other devices with a conical shape (i.e., the Amplatzer
Vascular Plug IV) do not offer [11].
In our study, there were no observed cases of HydroCoil
distal migrations, either during the early postimplantation
phase or when the late angiographic control was
performed.
Similar to other series that studied the performance of
HydroCoils in cranial aneurysm embolization, the results
of our study demonstrated that this material is an effective
Table 1 Comparison between
three different embolization
materials
Characteristic Pushable coils
(n = 25)
Fibered interlock detachable
coil (n = 25)
HydroCoil
(n = 23)
Embolization time (min) 14:32 2:15 2:47
Occlusion time (min) 17:18 11:19 13:02
Late recanalization (%) 4.3 None None
Mean number of devices 6 1.3 1
Cases requiring only one embolization
device according to study design (%)
0 83 100
Migrations (%) 4.3 4.3 None
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embolization tool in short- and long-term embolization
periods (up to 29 days) [12–14].
In conclusion, we demonstrated the successful use of a
single HydroCoil device for protective embolization of the
GDA, with complete early-term vascular occlusion rates
(during the first 30 min after embolization) in up to 91.3%
of the cases, and definitively in all the cases in median-term
vascular occlusion (up to 29 days). As demonstrated in our
study, this material is also a suitable alternative that pre-
vents extrahepatic embolization in radioembolization
procedures.
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